Many asthmatic suddenly cares taking Singulair, popular allergy and asthma medication. Singulair is now in a review of security of the FDA for its possible relation with suicide and depression. Doctors say that adults and children can continue to take the unique medication, but have to closely observe any signs of depression, suicidal behavior disorders and trends.
Also known as the montelukast singulair is used for the treatment of long-term asthma and to relieve the symptoms of seasonal allergies maintenance. While Singulair has been associated with side effects such as gastrointestinal disorders, hypersensitivity reactions, sleep disturbances and increase bleeding tendency of the highest incidence of depression in users is being investigated by the Food and drug us authority.
Secure Singulair was a drug for the treatment of asthma when introduced in 1998 blockbuster. Is a drug trafficking once a day gives the freedom to the inhaler for asthma Chronicle suffers as under the age of 6 years of age. Singulair, part of a new class called leukotrienes, inhibitors was approved by the Food and Drug Administration in February 1998. Helps to block the response of inflammation of the lung tissue that partly the cause of asthma. The food and drug in January 2003 approved pharmaceutical giant Merck & Co. Singulair for use in the fight against the (rhinitis) another common complaint hay fever. Singulair is widely prescribed to treat symptoms such as sneezing and a nose that is covered, discharge, or itching hay fever and asthma. Blocked a road of inflammation in the body that can cause asthma and allergy symptoms. Medical experts say Singulair is important for three reasons: tests showed few and minor side effects is convenient, and can be used by children as under the age of 6 years. The drug but not treat asthma attacks. The asthmatic has yet to take rapid action and rescue medication.
Merc holder of the patent and manufacturer of Singulair is working closely with the u.s. FDA last year to update the prescribing information and patient Singulair to include the possible risk of tremors, depression and trends information suicide.
